Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan
Clinical Drug Investigation · 2024
DOI: 10.1007/s40261-024-01352-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Drug Investigation, 2024. Verfasst von Teppei Hagino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Nippon Medical School, Chiba Hokusoh Hospital, Kamagari 1715, Inzai, Chiba, 270-1694, Japan. teppei-hagino@nms.ac.jp. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Janus Kinase Inhibitors, Eczema, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: MEXT.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Nippon Medical School, Chiba Hokusoh Hospital, Kamagari 1715, Inzai, Chiba, 270-1694, Japan. teppei-hagino@nms.ac.jp.
- Department of Dermatology, Nippon Medical School, Tokyo, Japan.
- Fujimoto Dermatology Clinic, Funabashi, Japan.
- Department of Dermatology, Nippon Medical School, Chiba Hokusoh Hospital, Kamagari 1715, Inzai, Chiba, 270-1694, Japan.
Förderung
- MEXT
Zitieren
APA
Hagino, T., Hamada, R., Yoshida, M., Saeki, H., Fujimoto, E., & Kanda, N. (2024). Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan. Clinical Drug Investigation. https://doi.org/10.1007/s40261-024-01352-4
Vancouver
Hagino T, Hamada R, Yoshida M, Saeki H, Fujimoto E, Kanda N. Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan. Clinical Drug Investigation. 2024. doi:10.1007/s40261-024-01352-4
BibTeX
@article{Hagino2024,
author = {Hagino, Teppei and Hamada, Risa and Yoshida, Mai and Saeki, Hidehisa and Fujimoto, Eita and Kanda, Naoko},
title = {Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan},
journal = {Clinical Drug Investigation},
year = {2024},
doi = {10.1007/s40261-024-01352-4}
}
EUVIMED